Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705286 · ClinicalTrials.gov registry record · Phase 2
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia
A Phase 2 study of Ventilator Acquired Pneumonia, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,074
- Enrollment target
- 1
- Study location
NCT03705286 is a Phase 2 study of Ventilator Acquired Pneumonia that has completed, run by Yale University. The registered enrollment target is 1,074 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03705286, a Phase 2 study of Ventilator Acquired Pneumonia, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,074 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are looking at two different types of breathing tubes to see if one is better than the other at preventing pneumonia. One of the tubes has a design features to prevent leakage of fluids from the mouth and the back of the throat into the lower airways and lungs. This is important since leakage of small amounts of fluid into the lungs may lead to pneumonia. The other tube is the standard tube used at most hospitals. The hypothesis is that the use of a breathing tube that reduces fluid leakage into the lungs will reduce the risk of developing pneumonia and improve quality of life and cognitive function, compared to the standard tube. The study will also look at the safety of the modified breathing tube, compared to the standard tube.
Conditions Studied
Interventions
- DEVICE EVAC-PU-ETT
- DEVICE PVC-ETT
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,074 participants |
| Start Date | 2019-05-06 |
| Est. Completion | 2023-02-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03705286
The ClinicalTrials.gov registry entry for NCT03705286 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,074 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventilator Acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which EVAC-PU-ETT is the first listed.
NCT03705286 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT03705286 about?
NCT03705286 is a clinical study titled "Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia". Researchers are looking at two different types of breathing tubes to see if one is better than the other at preventing pneumonia. One of the tubes has a design features to prevent leakage of fluids from the mouth and the back of the throat into the lower airways and lungs. This is important since le...
What is the current status of trial NCT03705286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,074 participants. The study started on 2019-05-06. Estimated completion is 2023-02-23.
What conditions does trial NCT03705286 study?
This clinical trial studies the following conditions: Ventilator Acquired Pneumonia.
What interventions are being tested in trial NCT03705286?
The interventions under investigation include: EVAC-PU-ETT (DEVICE), PVC-ETT (DEVICE).
Who is sponsoring clinical trial NCT03705286?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03705286 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilator Acquired Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.